The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Immune Responses to HCV and Other Hepatitis Viruses
Open accessAbstract
Summary Five human hepatitis viruses cause most acute and chronic liver disease worldwide. Over the past 25 years hepatitis C virus (HCV) in particular has received much interest because of its ability to persist in most immunocompetent adults and the lack of a protective vaccine. Here we examine innate and adaptive immune responses to HCV infection. Although HCV activates an innate immune response, it employs an elaborate set of mechanisms to evade interferon (IFN)-based antiviral immunity. By comparing innate and adaptive immune responses to HCV with those to hepatitis A and B viruses, we suggest that prolonged innate immune activation impairs the development of successful adaptive immune responses. Comparative immunology furthermore provides insights into the maintenance of immune protection. We conclude by discussing prospects for an HCV vaccine and future research needs for the hepatitis viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
Robust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., & Walker, B. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1499 · Cited by 1,269
Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection
Thimme, R., Oldach, D., Chang, K.-M., Steiger, C., Ray, S. C., & Chisari, F. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1395 · Cited by 1,189
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408824102 · Cited by 1,092
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Hansen, S. G., Ford, J. C., Lewis, M. S., Ventura, A. B., Hughes, C. M., Coyne-Johnson, L., Whizin, N., Oswald, K., Shoemaker, R., Swanson, T., et al. (2011) · Nature · doi:10.1038/nature10003 · Cited by 988
Prokunina-Olsson, L., Muchmore, B., Tang, W., Pfeiffer, R. M., Park, H., Dickensheets, H., Hergott, D., Porter-Gill, P., Mumy, A., Kohaar, I., et al. (2013) · Nature Genetics · doi:10.1038/ng.2521 · Cited by 928
Self-citationRehermann, B., Ferrari, C., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 854
Self-citationHCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J.-H., Hanson, H. L., Ghrayeb, J., Murthy, K. K., Rice, C. M., & Walker, C. M. (2003) · Science · doi:10.1126/science.1088774 · Cited by 830
Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease
Foy, E., Li, K., Wang, C., Sumpter, R., Ikeda, M., Lemon, S. M., & Gale, M. (2003) · Science · doi:10.1126/science.1082604 · Cited by 788
Persistent LCMV infection is controlled by blockade of type I interferon signaling
Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C. F., Welch, M., Schreiber, R. D., Carlos de la Torre, J., & Oldstone, M. B. A. (2013) · Science · doi:10.1126/science.1235214 · Cited by 755
Takaki, A., Wiese, M., Maertens, G., Depla, E., Seifert, U., Liebetrau, A., Miller, J. L., Manns, M. P., & Rehermann, B. (2000) · Nature Medicine · doi:10.1038/75063 · Cited by 739
Self-citationGerlach, J. T., Diepolder, H. M., Jung, M., Gruener, N. H., Schraut, W. W., Zachoval, R., Hoffmann, R., Schirren, C. A., Santantonio, T., & Pape, G. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70353-7 · Cited by 714
Blockade of chronic type I interferon signaling to control persistent LCMV infection
Wilson, E. B., Yamada, D. H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B. J., Karp, C. L., & Brooks, D. G. (2013) · Science · doi:10.1126/science.1235208 · Cited by 709
Diepolder, H. M., Zachoval, R., Hoffmann, R. M., Jung, M.-C., Pape, G. R., Wierenga, E. A., Santantonio, T., & Eichenlaub, D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91691-1 · Cited by 687
Missale, G., Bertoni, R., Lamonaca, V, Valli, A., Massari, M., Mori, C., Rumi, M. G., Houghton, M., Fiaccadori, F., & Ferrari, C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118842 · Cited by 658
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
Shoukry, N. H., Grakoui, A., Houghton, M., Chien, D. Y., Ghrayeb, J., Reimann, K. A., & Walker, C. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030239 · Cited by 656
Genomic analysis of the host response to hepatitis B virus infection
Wieland, S., Thimme, R., Purcell, R. H., & Chisari, F. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401771101 · Cited by 652
Interferon signaling and treatment outcome in chronic hepatitis C
Sarasin-Filipowicz, M., Oakeley, E. J., Duong, F. H. T., Christen, V., Terracciano, L., Filipowicz, W., & Heim, M. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707882105 · Cited by 642
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease
Thimme, R., Bukh, J., Spangenberg, H. C., Wieland, S., Pemberton, J., Steiger, C., Govindarajan, S., Purcell, R. H., & Chisari, F. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608299 · Cited by 639
Immune clearance of highly pathogenic SIV infection
Hansen, S. G., Jr, M. P., Ventura, A. B., Hughes, C. M., Gilbride, R. M., Ford, J. C., Oswald, K., Shoemaker, R., Li, Y., Lewis, M. S., et al. (2013) · Nature · doi:10.1038/nature12519 · Cited by 597
Reactivation of hepatitis B # †
Hoofnagle, J. H. (2009) · Hepatology · doi:10.1002/hep.22945 · Cited by 570
Pestka, J. M., Zeisel, M. B., Bläser, E., Schürmann, P., Bartosch, B., Cosset, F.-L., Patel, A. H., Meisel, H., Baumert, J., Viazov, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607026104 · Cited by 564
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
Scheel, T. K. H., & Rice, C. M. (2013) · Nature Medicine · doi:10.1038/nm.3248 · Cited by 554
Control of cccDNA function in hepatitis B virus infection
Levrero, M., Pollicino, T., Petersen, J., Belloni, L., Raimondo, G., & Dandri, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.022 · Cited by 552 · cited 3×
“, 1996) and cccDNA can persist in the form of a minichromosome (Levrero et al., 2009).”
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
Rehermann, B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39133 · Cited by 531
Self-citationExosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells
Ramakrishnaiah, V., Thumann, C., Fofana, I., Habersetzer, F., Pan, Q., de Ruiter, P. E., Willemsen, R., Demmers, J. A. A., Stalin Raj, V., Jenster, G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221899110 · Cited by 502
Radziewicz, H., Ibegbu, C. C., Fernandez, M. L., Workowski, K. A., Obideen, K., Wehbi, M., Hanson, H. L., Steinberg, J. P., Masopust, D., Wherry, E. J., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02021-06 · Cited by 483
Hoofnagle, J. H., Nelson, K. E., & Purcell, R. H. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1204512 · Cited by 479
Dreux, M., Garaigorta, U., Boyd, B., Décembre, E., Chung, J., Whitten-Bauer, C., Wieland, S., & Chisari, F. V. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.08.010 · Cited by 475
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Rehermann, B. (2013) · Nature Medicine · doi:10.1038/nm.3251 · Cited by 468
Self-citationCell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
Lindenbach, B. D., Meuleman, P., Ploss, A., Vanwolleghem, T., Syder, A. J., McKeating, J. A., Lanford, R. E., Feinstone, S. M., Major, M. E., Leroux-Roels, G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511218103 · Cited by 448
DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection
Bigger, C. B., Brasky, K. M., & Lanford, R. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7059-7066.2001 · Cited by 442
Protection against persistence of hepatitis C
Mehta, S. H., Cox, A., Hoover, D. R., Wang, X.-H., Mao, Q., Ray, S., Strathdee, S. A., Vlahov, D., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08435-0 · Cited by 440
Neutralizing antibody response during acute and chronic hepatitis C virus infection
Logvinoff, C., Major, M. E., Oldach, D., Heyward, S., Talal, A., Balfe, P., Feinstone, S. M., Alter, H., Rice, C. M., & McKeating, J. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403519101 · Cited by 433
Golden-Mason, L., Palmer, B. E., Kassam, N., Townshend-Bulson, L., Livingston, S., McMahon, B. J., Castelblanco, N., Kuchroo, V., Gretch, D. R., & Rosen, H. R. (2009) · Journal of Virology · doi:10.1128/jvi.00639-09 · Cited by 431
von Hahn, T., Yoon, J. C., Alter, H., Rice, C. M., Rehermann, B., Balfe, P., & McKeating, J. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.008 · Cited by 425
Self-citationPathogenesis of hepatitis B virus infection
Chisari, F. V., Isogawa, M., & Wieland., S. F. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2009.11.001 · Cited by 414
Negash, A. A., Ramos, H. J., Crochet, N., Lau, D. T. Y., Doehle, B., Papic, N., Delker, D. A., Jo, J., Bertoletti, A., Hagedorn, C. H., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003330 · Cited by 414
Oliviero, B., Varchetta, S., Paudice, E., Michelone, G., Zaramella, M., Mavilio, D., De Filippi, F., Bruno, S., & Mondelli, M. U. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.047 · Cited by 412
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Barnes, E., Folgori, A., Capone, S., Swadling, L., Aston, S., Kurioka, A., Meyer, J., Huddart, R., Smith, K., Townsend, R., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003155 · Cited by 405
Honda, M., Sakai, A., Yamashita, T., Nakamoto, Y., Mizukoshi, E., Sakai, Y., Yamashita, T., Nakamura, M., Shirasaki, T., Horimoto, K., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.049 · Cited by 400
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
Kong, L., Giang, E., Nieusma, T., Kadam, R. U., Cogburn, K. E., Hua, Y., Dai, X., Stanfield, R. L., Burton, D. R., Ward, A. B., et al. (2013) · Science · doi:10.1126/science.1243876 · Cited by 398
Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection
Loo, Y.-M., Owen, D. M., Li, K., Erickson, A. K., Johnson, C. L., Fish, P. M., Carney, D. S., Wang, T., Ishida, H., Yoneyama, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601523103 · Cited by 391
Timpe, J. M., Stamataki, Z., Jennings, A., Hu, K., Farquhar, M. J., Harris, H. J., Schwarz, A., Desombere, I., Roels, G. L., Balfe, P., et al. (2008) · Hepatology · doi:10.1002/hep.21959 · Cited by 389
The ins and outs of hepatitis C virus entry and assembly
Lindenbach, B. D., & Rice, C. M. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3098 · Cited by 387
Nakamoto, N., Cho, H., Shaked, A., Olthoff, K., Valiga, M. E., Kaminski, M., Gostick, E., Price, D. A., Freeman, G. J., Wherry, E. J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000313 · Cited by 380
Bengsch, B., Seigel, B., Ruhl, M., Timm, J., Kuntz, M., Blum, H. E., Pircher, H., & Thimme, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000947 · Cited by 373
Golden-Mason, L., Palmer, B., Klarquist, J., Mengshol, J. A., Castelblanco, N., & Rosen, H. R. (2007) · Journal of Virology · doi:10.1128/jvi.00409-07 · Cited by 371
Urban, T. J., Thompson, A. J., Bradrick, S. S., Fellay, J., Schuppan, D., Cronin, K. D., Hong, L., McKenzie, A., Patel, K., Shianna, K. V., et al. (2010) · Hepatology · doi:10.1002/hep.23912 · Cited by 361
Osburn, W. O., Fisher, B. E., Dowd, K. A., Urban, G., Liu, L., Ray, S. C., Thomas, D. L., & Cox, A. L. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.017 · Cited by 360
Folgori, A., Capone, S., Ruggeri, L., Meola, A., Sporeno, E., Ercole, B. B., Pezzanera, M., Tafi, R., Arcuri, M., Fattori, E., et al. (2006) · Nature Medicine · doi:10.1038/nm1353 · Cited by 322
Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor
Yang, Y., Liang, Y., Qu, L., Chen, Z., Yi, M., Li, K., & Lemon, S. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611506104 · Cited by 320
The size of the viral inoculum contributes to the outcome of hepatitis B virus infection
Asabe, S., Wieland, S. F., Chattopadhyay, P. K., Roederer, M., Engle, R. E., Purcell, R. H., & Chisari, F. V. (2009) · Journal of Virology · doi:10.1128/jvi.00867-09 · Cited by 320
Franceschini, D., Paroli, M., Francavilla, V., Videtta, M., Morrone, S., Labbadia, G., Cerino, A., Mondelli, M. U., & Barnaba, V. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36604 · Cited by 318
CD8 Epitope Escape and Reversion in Acute HCV Infection
Timm, J., Lauer, G. M., Kavanagh, D. G., Sheridan, I., Kim, A. Y., Lucas, M., Pillay, T., Ouchi, K., Reyor, L. L., zur Wiesch, J. S., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041006 · Cited by 318
McMahan, R. H., Golden-Mason, L., Nishimura, M. I., McMahon, B. J., Kemper, M., Allen, T. M., Gretch, D. R., & Rosen, H. R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43127 · Cited by 305
Österlund, P. I., Pietilä, T. E., Veckman, V., Kotenko, S. V., & Julkunen, I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3434 · Cited by 301
Regulation of hepatic innate immunity by hepatitis C virus
Horner, S. M., & Gale, M. (2013) · Nature Medicine · doi:10.1038/nm.3253 · Cited by 278
Ahlenstiel, G., Titerence, R. H., Koh, C., Edlich, B., Feld, J. J., Rotman, Y., Ghany, M. G., Hoofnagle, J. H., Liang, T. J., Heller, T., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.08.066 · Cited by 270
Self-citationTakahashi, K., Asabe, S., Wieland, S., Garaigorta, U., Gastaminza, P., Isogawa, M., & Chisari, F. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002301107 · Cited by 269
Thomas, E., Gonzalez, V. D., Li, Q., Modi, A. A., Chen, W., Noureddin, M., Rotman, Y., & Liang, T. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.055 · Cited by 266
Dill, M. T., Duong, F. H. T., Vogt, J. E., Bibert, S., Bochud, P., Terracciano, L., Papassotiropoulos, A., Roth, V., & Heim, M. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.039 · Cited by 250
Hepatitis C Virus Blocks Interferon Effector Function by Inducing Protein Kinase R Phosphorylation
Garaigorta, U., & Chisari, F. V. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.11.004 · Cited by 228
De Maria, A., Fogli, M., Mazza, S., Basso, M., Picciotto, A., Costa, P., Congia, S., Mingari, M. C., & Moretta, L. (2007) · European Journal of Immunology · doi:10.1002/eji.200635989 · Cited by 220
Wang, N., Liang, Y., Devaraj, S., Wang, J., Lemon, S. M., & Li, K. (2009) · Journal of Virology · doi:10.1128/jvi.01125-09 · Cited by 209
Kasprowicz, V., Schulze zur Wiesch, J., Kuntzen, T., Nolan, B. E., Longworth, S., Berical, A., Blum, J., McMahon, C., Reyor, L. L., Elias, N., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02474-07 · Cited by 202
Urbani, S., Amadei, B., Fisicaro, P., Tola, D., Orlandini, A., Sacchelli, L., Mori, C., Missale, G., & Ferrari, C. (2006) · Hepatology · doi:10.1002/hep.21242 · Cited by 198
Nascimbeni, M., Mizukoshi, E., Bosmann, M., Major, M. E., Mihalik, K., Rice, C. M., Feinstone, S. M., & Rehermann, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4781-4793.2003 · Cited by 194
Self-citationLi, K., Li, N. L., Wei, D., Pfeffer, S. R., Fan, M., & Pfeffer, L. M. (2012) · Hepatology · doi:10.1002/hep.24763 · Cited by 190
Preferential loss of IL‐2–secreting CD4+ T helper cells in chronic HCV infection†
Semmo, N., Day, C. L., Ward, S. M., Lucas, M., Harcourt, G., Loughry, A., & Klenerman, P. (2005) · Hepatology · doi:10.1002/hep.20669 · Cited by 186
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
Shin, E.-C., Seifert, U., Kato, T., Rice, C. M., Feinstone, S. M., Kloetzel, P.-M., & Rehermann, B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29832 · Cited by 185
Self-citationWieland, S., Makowska, Z., Campana, B., Calabrese, D., Dill, M. T., Chung, J., Chisari, F. V., & Heim, M. H. (2014) · Hepatology · doi:10.1002/hep.26770 · Cited by 180
Cross-Genotype Immunity to Hepatitis C Virus
Lanford, R. E., Guerra, B., Chavez, D., Bigger, C., Brasky, K. M., Wang, X.-H., Ray, S. C., & Thomas, D. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.3.1575-1581.2004 · Cited by 178
Miyagi, T., Gil, M. P., Wang, X., Louten, J., Chu, W.-M., & Biron, C. A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070401 · Cited by 174
Fuller, M. J., Callendret, B., Zhu, B., Freeman, G. J., Hasselschwert, D. L., Satterfield, W., Sharpe, A. H., Dustin, L. B., Rice, C. M., Grakoui, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312772110 · Cited by 173
Visualizing Hepatitis C Virus Infections in Human Liver by Two-Photon Microscopy
Liang, Y., Shilagard, T., Xiao, S., Snyder, N., Lau, D., Cicalese, L., Weiss, H., Vargas, G., & Lemon, S. M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.050 · Cited by 171
Lanford, R. E., Feng, Z., Chavez, D., Guerra, B., Brasky, K. M., Zhou, Y., Yamane, D., Perelson, A. S., Walker, C. M., & Lemon, S. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101939108 · Cited by 167
Galectin-9 and IL-21 Mediate Cross-regulation between Th17 and Treg Cells during Acute Hepatitis C
Kared, H., Fabre, T., Bédard, N., Bruneau, J., & Shoukry, N. H. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003422 · Cited by 165
25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end
Heim, M. H. (2013) · Nature reviews. Immunology · doi:10.1038/nri3463 · Cited by 165
Current progress in development of hepatitis C virus vaccines
Liang, T. J. (2013) · Nature Medicine · doi:10.1038/nm.3183 · Cited by 155
Ahlenstiel, G., Edlich, B., Hogdal, L. J., Rotman, Y., Noureddin, M., Feld, J. J., Holz, L. E., Titerence, R. H., Liang, T. J., & Rehermann, B. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.069 · Cited by 150
Self-citationInterferon-lambda serum levels in hepatitis C
Langhans, B., Kupfer, B., Braunschweiger, I., Arndt, S., Schulte, W., Nischalke, H. D., Nattermann, J., Oldenburg, J., Sauerbruch, T., & Spengler, U. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.020 · Cited by 147
McFarland, A. P., Horner, S. M., Jarret, A. P., Joslyn, R. C., Bindewald, E., Shapiro, B. A., Delker, D. A., Hagedorn, C. H., Carrington, M. N., Gale, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2758 · Cited by 147
Effects of antiviral therapy on the cellular immune response in acute hepatitis C
Rahman, F., Heller, T., Sobao, Y., Mizukoshi, E., Nascimbeni, M., Alter, H. J., Herrine, S. K., Hoofnagle, J. H., Liang, J. T., & Rehermann, B. (2004) · Hepatology · doi:10.1002/hep.20253 · Cited by 145
Self-citationPark, H., Serti, E., Eke, O. F., Muchmore, B., Prokunina‐Olsson, L., Capone, S., Folgori, A., & Rehermann, B. (2012) · Hepatology · doi:10.1002/hep.25897 · Cited by 143
Self-citationQu, L., Feng, Z., Yamane, D., Liang, Y., Lanford, R. E., Li, K., & Lemon, S. M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002169 · Cited by 141
Bellecave, P., Sinnreich, M. F., Donzé, O., Kennel, A., Gouttenoire, J., Meylan, E., Terracciano, L., Tschopp, J., Sarrazin, C., Berg, T., et al. (2009) · Hepatology · doi:10.1002/hep.23426 · Cited by 133
Dual Function of the NK Cell Receptor 2B4 (CD244) in the Regulation of HCV-Specific CD8+ T Cells
Schlaphoff, V., Lunemann, S., Suneetha, P. V., Jaroszewicz, J., Grabowski, J., Dietz, J., Helfritz, F., Bektas, H., Sarrazin, C., Manns, M. P., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002045 · Cited by 132
Dazert, E., Neumann‐Haefelin, C., Bressanelli, S., Fitzmaurice, K., Kort, J. C., Timm, J., McKiernan, S. M., Kelleher, D. P., Gruener, N. H., Tavis, J. E., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36587 · Cited by 123
Cheng, G., Zhong, J., & Chisari, F. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602957103 · Cited by 120
Edlich, B., Ahlenstiel, G., Zabaleta, A., Stoltzfus, J., Noureddin, M., Serti, E., Feld, J. J., Liang, J. T., Rotman, Y., & Rehermann, B. (2011) · Hepatology · doi:10.1002/hep.24628 · Cited by 110
Self-citationZhang, S., Kodys, K., Li, K., & Szabó, G. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.10.034 · Cited by 109
Cell culture–produced hepatitis C virus impairs plasmacytoid dendritic cell function
Shiina, M., & Rehermann, B. (2007) · Hepatology · doi:10.1002/hep.21996 · Cited by 109
Self-citationKroy, D. C., Ciuffreda, D., Cooperrider, J. H., Tomlinson, M., Hauck, G. D., Aneja, J., Berger, C. T., Wolski, D., Carrington, M. N., Wherry, E. J., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.022 · Cited by 109
Lau, D., Fish, P. M., Sinha, M., Owen, D. M., Lemon, S. M., & Gale, M. (2008) · Hepatology · doi:10.1002/hep.22076 · Cited by 106
Raziorrouh, B., Ulsenheimer, A., Schraut, W., Heeg, M. H. J., Kurktschiev, P., Zachoval, R., Jung, M., Thimme, R., Neumann‐Haefelin, C., Horster, S., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.004 · Cited by 105
Interferon-stimulated genes and their role in controlling hepatitis C virus
Metz, P., Reuter, A., Bender, S., & Bartenschlager, R. F. W. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.033 · Cited by 95
Dominance of the CD4+ T helper cell response during acute resolving hepatitis A virus infection
Zhou, Y., Callendret, B., Xu, D., Brasky, K. M., Feng, Z., Hensley, L., Guedj, J., Perelson, A. S., Lemon, S. M., Lanford, R. E., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111906 · Cited by 93
Smyk‐Pearson, S., Tester, I. A., Klarquist, J. S., Palmer, B. E., Pawlotsky, J., Golden‐Mason, L., & Rosen, H. R. (2007) · Journal of Virology · doi:10.1128/jvi.01581-07 · Cited by 87
Lau, D., Negash, A. A., Chen, J., Crochet, N., Sinha, M., Zhang, Y., Guedj, J., Holder, S., Saito, T., Lemon, S. M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.10.044 · Cited by 78
Taylor, J. M. (2012) · Seminars in Liver Disease · doi:10.1055/s-0032-1323623 · Cited by 76
Fuller, M. J., Shoukry, N. H., Gushima, T., Bowen, D. G., Callendret, B., Campbell, K. J., Hasselschwert, D. L., Hughes, A. L., & Walker, C. M. (2009) · Hepatology · doi:10.1002/hep.23319 · Cited by 72
Honegger, J. R., Kim, S., Price, A. A., Kohout, J. A., McKnight, K. L., Prasad, M. R., Lemon, S. M., Grakoui, A., & Walker, C. M. (2013) · Nature Medicine · doi:10.1038/nm.3351 · Cited by 70
Park, S., Shin, E., Capone, S., Caggiari, L., Re, V. D., Nicosia, A., Folgori, A., & Rehermann, B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.005 · Cited by 67
Self-citationMizukoshi, E., Eisenbach, C., Edlin, B. R., Newton, K. P., Raghuraman, S., Weiler‐Normann, C., Tobler, L. H., Busch, M. P., Carrington, M. N., McKeating, J. A., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/589510 · Cited by 65
Self-citationThurairajah, P. H., Hegazy, D., Chokshi, S., Shaw, S. R., Demaine, A. G., Kaminski, E. R., Naoumov, N. V., & Cramp, M. (2008) · The Journal of Infectious Diseases · doi:10.1086/593337 · Cited by 54
Park, S., Veerapu, N. S., Shin, E., Biancotto, A., McCoy, J. P., Capone, S., Folgori, A., & Rehermann, B. (2013) · Nature Medicine · doi:10.1038/nm.3408 · Cited by 49
Self-citationShin, E., Park, S., Nascimbeni, M., Major, M. E., Caggiari, L., Re, V. D., Feinstone, S. M., Rice, C. M., & Rehermann, B. (2013) · Journal of Virology · doi:10.1128/jvi.03122-12 · Cited by 48
Self-citationHeller, T., Werner, J. M., Rahman, F., Mizukoshi, E., Sobao, Y., Gordon, A. M., Sheets, A., Sherker, A. H., Kessler, E. R., Bean, K. S., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit270 · Cited by 34
Self-citation
Cited by
Liver immunology and its role in inflammation and homeostasis
Robinson, M. W., Harmon, C., & O’Farrelly, C. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.3 · Cited by 1,151
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Nassal, M. (2015) · Gut · doi:10.1136/gutjnl-2015-309809 · Cited by 899
Peptide-Based Vaccines: Current Progress and Future Challenges
Malonis, R. J., Lai, J. R., & Vergnolle, O. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00472 · Cited by 602
Manns, M. P., Buti, M., Gane, E., Pawlotsky, J.-M., Razavi, H., Terrault, N., & Younossi, Z. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.6 · Cited by 506
The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
Sarrazin, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.09.011 · Cited by 423
Metadata
- Authors
- Park, S.-H., & Rehermann, B.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 40
- Issue
- 1
- Pages
- 13-24
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2028368003
- Cited by
- 265
- References
- 115
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.